Fragments of ATM Which Have Dominant-Negative or Complementing Activity

REFERENCES

• Al-Khodairy, F., E. Fotou, K. S. Sheldrick, D. J. F. Griffiths, A. R. Lehmann, and A. M. Carr. 1994. Identification and characterization of new elements involved in checkpoint and feedback controls in fission yeast. Mol. Biol. Cell 5:147–160.
   PubMed Web of Science ®Google Scholar
• Allen, J. B., Z. Zhou, W. Siede, E. C. Friedberg, and S. J. Elledge. 1994. The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast. Genes Dev. 8:2401–2415.
   PubMed Web of Science ®Google Scholar
• Beamish, H., K. K. Khanna, and M. F. Lavin. 1994. Ionizing radiation and cell cycle progression in ataxia telangiectasia. Radiat. Res. 138:S130–S133.
   PubMedGoogle Scholar
• Brown, E. J., M. W. Albers, T. B. Shin, K. Ichikawa, C. T. Keith, W. S. Lane, and S. L. Schreiber. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756–758.
   PubMed Web of Science ®Google Scholar
• Byrd, P. J., C. M. McConville, P. Cooper, J. Parkhill, T. Stankovic, G. M. McGuire, J. A. Thick, and A. M. R. Taylor. 1996. Mutations revealed by sequencing the 5-prime half of the gene for ataxia-telangiectasia. Hum. Mol. Genet. 5:145–149.
   PubMedGoogle Scholar
• Canman, C. E., A. C. Wolff, C. Chen, A. J. Fornace, and M. B. Kastan. 1994. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54:5054–5058.
   PubMed Web of Science ®Google Scholar
• Chen, P., A. A. Girjes, K. Hobson, H. Beamish, K. K. Khanna, A. Farrell, M. Gatei, B. Teale, M. Buchwald, R. Legerski, and M. F. Lavin. 1996. Genetic complementation of radiation response by 3′ untranslated regions (UTR) of RNA. Int. J. Radiat. Biol. 69:385–395.
   PubMed Web of Science ®Google Scholar
• Dang, C. V., M. McGuire, M. Buckmire, and W. M. F. Lee. 1989. Involvement of the “leucine zipper” region in the oligomerization and transforming activity of human c-myc protein. Nature 337:664–666.
   PubMed Web of Science ®Google Scholar
• Dhand, R., I. Hiles, G. Panayotou, S. Roche, M. J. Fry, I. Gout, N. F. Totty, O. Truong, P. Vicendo, K. Yonezawa, M. Kasuga, S. A. Courtneidge, and M. D. Waterfield. 1994. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13:522–533.
   PubMed Web of Science ®Google Scholar
• Enoch, T., and C. Norbury. 1995. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20:426–430.
   PubMed Web of Science ®Google Scholar
• Freund, G. G., J. G. Wittig, and R. A. Mooney. 1995. The PI3-kinase serine kinase phosphorylates its p85 subunit and IRS-1 in PI3-kinase/IRS-1 complexes. Biochem. Biophys. Res. Commun. 206:272–278.
   PubMedGoogle Scholar
• Gatti, R. A., E. Boder, H. V. Vinters, R. S. Sparkes, A. Norman, and K. Lange. 1991. Ataxia-telangeictasia: an interdisciplinary approach to pathogenesis. Medicine 70:99–117.
   PubMed Web of Science ®Google Scholar
• Gibbas, L. M., and L. G. Jackson. 1985. A new hypotonic solution for cytogenetic analysis of leukemic bone marrow cells. Karyogram 11:91–92.
   Google Scholar
• Gilad, S., R. Khosravi, D. Shkedy, T. Uziel, Y. Ziv, K. Savitsky, G. Rotman, S. Smith, L. Chessa, T. J. Jorgensen, R. Harnik, M. Frydman, O. Sanal, S. Portnoi, Z. Goldwicz, N. G. J. Jaspers, R. A. Gatti, G. Lenoir, M. F. Lavin, K. Tatsumi, R. D. Wegner, Y. Shiloh, and A. Bar-Shira. 1996. Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet. 5:433–439.
   PubMed Web of Science ®Google Scholar
• Gottlieb, T. M., and S. P. Jackson. 1993. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72:131–142.
   PubMed Web of Science ®Google Scholar
• Granger-Schnarr, M., E. Benusiglio, M. Schnarr, and P. Sassone-Corsi. 1992. Transformation and transactivation suppressor activity of the c-Jun leucine zipper fused to a bacterial repressor. Proc. Natl. Acad. Sci. USA 89:4236–4239.
   PubMedGoogle Scholar
• Greenwell, P. W., S. L. Krommal, S. E. Porter, J. Gassenhuber, B. Obermaier, and T. D. Petes. 1995. Tel1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 82:823–829.
   PubMed Web of Science ®Google Scholar
• Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42–52.
   PubMed Web of Science ®Google Scholar
• Hari, K. L., A. Santerre, J. J. Sekelsky, K. S. McKim, J. B. Boyd, and R. S. Hawley. 1995. The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell 82:815–821.
   PubMed Web of Science ®Google Scholar
• Harnden, D. G. 1994. The nature of ataxia-telangiectasia: problems and perspectives. Int. J. Radiat. Biol. 66:S13–19.
   PubMed Web of Science ®Google Scholar
• Hartley, K. O., D. Gell, G. C. M. Smith, H. Zhang, N. Divecha, M. A. Connelly, A. Admon, S. P. Lees-Miller, C. W. Anderson, and S. P. Jackson. 1995. DNA-dependent protein kinase catalytic subunit—a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849–856.
   PubMed Web of Science ®Google Scholar
• Hecht, F., and B. K. Hecht. 1990. Cancer in ataxia-telangiectasia patients. Cancer Genet. Cytogenet. 46:9–19.
   PubMedGoogle Scholar
• Heitman, J., N. R. Movva, and M. N. Hall. 1991. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253:905–909.
   PubMed Web of Science ®Google Scholar
• Helliwell, S. B., P. Wagner, J. Kunz, M. Deuter-Reinhard, R. Henriquez, and M. N. Hall. 1994. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell 5:105–118.
   PubMed Web of Science ®Google Scholar
• Hiles, I. D., M. Otsu, S. Volinia, M. J. Fry, I. Gout, R. Dhand, G. Panayotou, F. Ruiz-Larrea, A. Thompson, H. F. Totty, J. J. Hsuan, S. A. Courtneidge, P. J. Parker, and M. Waterfield. 1992. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70:419–429.
   PubMed Web of Science ®Google Scholar
• Houldsworth, J., and M. F. Lavin. 1980. Effect of ionizing radiation on DNA synthesis in ataxia-telangiectasia cells. Nucleic Acids Res. 8:3709–3720.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587–597.
   PubMed Web of Science ®Google Scholar
• Kato, J., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713–2721.
   PubMed Web of Science ®Google Scholar
• Khanna, K. K., and M. F. Lavin. 1993. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8:3307–3312.
   PubMed Web of Science ®Google Scholar
• Kobayashi, Y., B. Tycko, A. L. Soreng, and J. Sklar. 1991. Transrearrangements between antigen receptor genes in normal human lymphoid tissues and in ataxia telangiectasia. J. Immunol. 147:3201–3209.
   PubMed Web of Science ®Google Scholar
• Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491–7495.
   PubMed Web of Science ®Google Scholar
• Kunz, J., R. Henriquez, U. Schneider, M. Deuter-Reinhard, N. R. Movva, and M. N. Hall. 1993. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73:585–596.
   PubMed Web of Science ®Google Scholar
• Larner, J. M., H. Lee, and J. L. Hamlin. 1994. Radiation effects on DNA synthesis in a defined chromosomal replicon. Mol. Cell. Biol. 14:1901–1908.
   PubMedGoogle Scholar
• Lipkowitz, S., M. H. Stern, and I. R. Kirsh. 1990. Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J. Exp. Med. 172:409–418.
   PubMed Web of Science ®Google Scholar
• Lydall, D., and T. Weinert. 1995. Yeast checkpoint genes in DNA damage processing: implications for repair and arrest. Science 270:1488–1491.
   PubMed Web of Science ®Google Scholar
• McKinnon, P. J. 1987. Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect. Hum. Genet. 75:197–208.
   PubMed Web of Science ®Google Scholar
• Meyn, M. S. 1993. High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science 260:1327–1330.
   PubMed Web of Science ®Google Scholar
• Meyn, M. S., J. M. Lu-Kuo, and L. B. Herring. 1993. Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxiatelangiectasia group D fibroblasts. Am. J. Hum. Genet. 53:1206–1216.
   PubMed Web of Science ®Google Scholar
• Miller, A. D., D. G. Miller, J. G. Victor, and C. M. Lynch. 1993. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217:581–599.
   PubMed Web of Science ®Google Scholar
• Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587–3596.
   PubMed Web of Science ®Google Scholar
• Morrow, D. M., D. A. Tagle, Y. Shiloh, F. S. Collins, and P. Hieter. 1995. TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell 82:831–840.
   PubMed Web of Science ®Google Scholar
• Nagasawa, H., S. A. Latt, M. E. Lalande, and J. B. Little. 1985. Effects of X-irradiation on cell-cycle progression, induction of chromosomal aberrations and cell killing in ataxia-telangiectasia (AT) fibroblasts. Mutat. Res. 148:71–82.
   PubMed Web of Science ®Google Scholar
• Painter, R. B., and B. R. Young. 1980. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA 77:7315–7317.
   PubMed Web of Science ®Google Scholar
• Pandita, T. K., S. Pathak, and C. R. Geard. 1995. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet. Cell Genet. 71:86–93.
   PubMedGoogle Scholar
• Pandita, T. K., and C. R. Geard. 1996. Chromosome aberrations in human fibroblasts induced by monoenergetic neutrons. 1. Relative biological effectiveness. Radiat. Res. 145:730–739.
   PubMed Web of Science ®Google Scholar
• Pandita, T. K., E. J. Hall, T. K. Hei, M. A. Piatyszek, W. E. Wright, C. Q. Piao, R. K. Pandita, J. C. Willey, R. C. Geard, M. B. Kastan, and J. W. Shay. 1996. Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles stimulating radon progeny. Oncogene 13:1423–1430.
   PubMedGoogle Scholar
• Pandita, T. K., and W. N. Hittelman. 1992. The contribution of DNA and chromosome repair deficiencies to the radiosensitivity of ataxia-telangiectasia. Radiat. Res. 131:214–223.
   PubMed Web of Science ®Google Scholar
• Paules, R. S., E. N. Levedakou, S. J. Wilson, C. L. Innes, N. Rhodes, T. D. Tlsty, D. A. Galloway, L. A. Donehower, M. A. Tainsky, and W. K. Kaufmann. 1995. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res. 55:1763–1773.
   PubMed Web of Science ®Google Scholar
• Sabatini, D. M., H. Erdjument-Bromage, M. Lui, P. Tempst, and S. H. Snyder. 1994. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35–43.
   PubMed Web of Science ®Google Scholar
• Sabers, C. J., M. M. Martin, G. J. Brunn, J. M. Williams, F. J. Dumont, G. Wiederrecht, and R. T. Abraham. 1995. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270:815–822.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Sanchez, Y., B. A. Desany, W. J. Jones, Q. Liu, B. Wang, and S. J. Elledge. 1996. Regulation of Rad53 by the ATM-like kinases Mec1 and Tel1 in yeast cell cycle checkpoint pathways. Science 271:357–360.
   PubMed Web of Science ®Google Scholar
• Savitsky, K., A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D. A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S. R. Patanjali, A. Simmons, G. A. Clines, A. Sartiel, R. A. Gatti, L. Chessa, O. Sanal, M. F. Lavin, N. G. J. Jaspers, A. M. R. Taylor, C. F. Arlett, T. Miki, S. M. Weissman, M. Lovett, F. S. Collins, and Y. Shiloh. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749–1753.
   PubMed Web of Science ®Google Scholar
• Savitsky, K., S. Sfez, D. A. Tagle, A. Sartiel, F. S. Collins, Y. Shiloh, and G. Rotman. 1995. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4:2025–2032.
   PubMed Web of Science ®Google Scholar
• Shiloh, Y. 1995. Ataxia-telangiectasia: closer to unraveling the mystery. Eur. J. Hum. Genet. 3:116–138.
   PubMed Web of Science ®Google Scholar
• Stan, R., M. M. McLaughlin, R. Cafferkey, R. K. Johnson, M. Rosenberg, and G. P. Livi. 1994. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J. Biol. Chem. 269:32027–32030.
   PubMed Web of Science ®Google Scholar
• Sun, Z., D. S. Fay, F. Marini, M. Foiani, and D. F. Stern. 1996. Spk1/Rad53 is regulated by Mec1-dependent protein phosphorylation in DNA replication and damage checkpoint pathways. Genes Dev. 10:395–406.
   PubMed Web of Science ®Google Scholar
• Swift, M., D. Morrell, R. B. Massey, and C. L. Chase. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med. 325:1831–1836.
   PubMed Web of Science ®Google Scholar
• Swift, M., P. J. Reitnauer, D. Morrell, and C. L. Chase. 1987. Breast and other cancers in families affected by ataxia-telangeictasia. N. Engl. J. Med. 316:1289–1294.
   PubMed Web of Science ®Google Scholar
• Taccioli, G. E., T. M. Gottlieb, T. Blunt, A. Priestley, J. Demengeot, R. Mizuta, A. R. Lehmann, F. W. Alt, S. P. Jackson, and P. A. Jeggo. 1994. Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 265:1442–1445.
   PubMed Web of Science ®Google Scholar
• Tanti, J. F., T. Gremeaux, E. Van Obberghen, and Y. LeMarchand-Brustel. 1994. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem. J. 304:17–21.
   PubMedGoogle Scholar
• Tuteja, N., M. Meyer, K. K. Reddy, J. R. Falck, R. Aneja, A. Parra, D. J. Burns, L. M. Ballas, and L. C. Cantley. 1994. Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen. J. Biol. Chem. 269:32358–32367.
   PubMedGoogle Scholar
• Weinert, T. A., G. L. Kiser, and L. H. Hartwell. 1994. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 8:652–665.
   PubMed Web of Science ®Google Scholar
• Yao, K.-S., M. Clayton, and P. J. O’Dwyer. 1995. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J. Natl. Cancer Inst. 87:117–122.
   PubMedGoogle Scholar
• Ziv, Y., A. Bar-Shira, T. J. Jorgensen, P. S. Russell, A. Sartiel, T. B. Shows, R. L. Eddy, M. Buchwald, R. Legerski, R. T. Schimke et al. 1995. Human cDNA clones that modify radiomimetic sensitivity of ataxia-telangiectasia (group A) cells. Somatic Cell Mol. Genet. 21:99–111.
   PubMedGoogle Scholar